Fritz,
A combination of different things coming together.
1. T/A= my gut feel type, not Hew's purely technical read. Oversold, triangle as tight as it could get and had to break soon with small break up today on decent volume. Recent big short increase at low prices with little effect. Feeling that retail shaking is slowing. Good base built. Several indicators have or are turning. Lots of little things coming together at the same time and combined with news could break the shorts grip. With institutions adding, shorts increasing, retail hopefully getting stronger, the supply has to be drying up.
2. News= Cheetah full Phase I data and IND with new trial. HTI-501 small now but helps. Chemophase data and update on next step. Baxter updates due any day but could be Q3. News on several other fronts could come soon.
Mainly technical with news for a boost through some key resistance levels hitting at the right time. We are close to a break out and it wont take much imo. Just a strong feeling everthing is coming together for a good little run setting up the big run on big news later. Remember the boys have to get us over $7 to get that bonus. A break over $7.50 and we should retrace back to $10 on technicals. Get insti's, shorts, retail and momo players competing for shares.
Nope, don't think Mr. Kirk can buy now. Too much insider news coming.
That's some of my thoughts and worth what you paid for it.
Good Luck,
Rod
A combination of different things coming together.
1. T/A= my gut feel type, not Hew's purely technical read. Oversold, triangle as tight as it could get and had to break soon with small break up today on decent volume. Recent big short increase at low prices with little effect. Feeling that retail shaking is slowing. Good base built. Several indicators have or are turning. Lots of little things coming together at the same time and combined with news could break the shorts grip. With institutions adding, shorts increasing, retail hopefully getting stronger, the supply has to be drying up.
2. News= Cheetah full Phase I data and IND with new trial. HTI-501 small now but helps. Chemophase data and update on next step. Baxter updates due any day but could be Q3. News on several other fronts could come soon.
Mainly technical with news for a boost through some key resistance levels hitting at the right time. We are close to a break out and it wont take much imo. Just a strong feeling everthing is coming together for a good little run setting up the big run on big news later. Remember the boys have to get us over $7 to get that bonus. A break over $7.50 and we should retrace back to $10 on technicals. Get insti's, shorts, retail and momo players competing for shares.
Nope, don't think Mr. Kirk can buy now. Too much insider news coming.
That's some of my thoughts and worth what you paid for it.
Good Luck,
Rod
Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.
Recent HALO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 09:13:42 PM
- Halozyme signs licensing deal with Vertex for drug delivery technology • IH Market News • 04/07/2026 02:11:29 PM
- Halozyme Announces Global Collaboration and License Agreement with Vertex Pharmaceuticals for Hypercon™ Technology • PR Newswire (US) • 04/07/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:29:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 10:28:38 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 10:35:07 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/23/2026 08:16:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/23/2026 08:13:32 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/23/2026 08:11:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2026 12:32:00 PM
- Halozyme Appoints David Ramsay as Interim Chief Financial Officer • PR Newswire (US) • 03/12/2026 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/10/2026 08:05:17 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/09/2026 08:18:04 PM
- U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma • PR Newswire (US) • 03/06/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 11:56:16 PM
- Halozyme to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/25/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:19:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:16:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2026 11:12:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:52:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2026 11:51:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 09:04:55 PM
- HALOZYME REPORTS FULL YEAR 2025 RECORD REVENUE OF $1.4 BILLION AND REITERATES STRONG 2026 FINANCIAL GUIDANCE • PR Newswire (US) • 02/17/2026 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2026 02:21:33 AM
